Pseudoephedrine
Pseudoephedrine is a sympathomimetic amine that acts as a direct alpha-adrenergic receptor agonist and indirect sympathomimetic to cause vasoconstriction of nasal mucosal blood vessels, reducing nasal congestion and improving airway patency. It is used as an oral nasal decongestant for the symptomatic relief of nasal congestion associated with the common cold, sinusitis, and allergic rhinitis, and is also a precursor in the illicit synthesis of methamphetamine.
Peso molecular
165,2300 g/mol
LogP
0,90
TPSA
32,30 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.
Estructura 2D
Cite this structure
Embed this structure
SMILES
CN[C@@H](C)[C@@H](O)c1ccccc1
InChI
InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1
Molecular Formula
C10H15NO
HBD / HBA
2 / 2
Enlaces Rotables
3
Átomos Pesados
12
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
Pseudoephedrine is a sympathomimetic amine that acts as a direct alpha-adrenergic receptor agonist and indirect sympathomimetic to cause vasoconstriction of nasal mucosal blood vessels, reducing nasal congestion and improving airway patency. It is used as an oral nasal decongestant for the symptomatic relief of nasal congestion associated with the common cold, sinusitis, and allergic rhinitis, and is also a precursor in the illicit synthesis of methamphetamine.
Binds to and activates its target receptor, mimicking the action of the endogenous ligand to produce a specific physiological response.
Yes, Pseudoephedrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1590. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 7028. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="pseudoephedrine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/pseudoephedrine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/pseudoephedrine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/pseudoephedrine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="pseudoephedrine"></drugfyi-drug>